Literature DB >> 29510241

A male case with CDKL5-associated encephalopathy manifesting transient methylmalonic acidemia.

Satoshi Akamine1, Yoshito Ishizaki1, Yasunari Sakai2, Hiroyuki Torisu3, Ryoko Fukai4, Noriko Miyake4, Kazuhiro Ohkubo1, Hiroshi Koga1, Masafumi Sanefuji1, Ayumi Sakata5, Masahiko Kimura6, Seiji Yamaguchi6, Osamu Sakamoto7, Toshiro Hara1, Hirotomo Saitsu8, Naomichi Matsumoto4, Shouichi Ohga1.   

Abstract

Mutations in the X-linked gene CDKL5 cause early-onset epileptic encephalopathy and severe developmental delay. Because this disorder predominantly affects females, the full clinical spectrum of male patients remains elusive. We herein report a 16-year-old boy, who suffered from intractable seizures 20 days after birth. Serial electroencephalograms detected recurrent focal epileptiform discharges from age 4 months, which evolved to hypsarrhythmia later in infancy. Mass-spectrometric analyses revealed increase in urinary excretion of methylmalonic acid without perturbed concentrations of propionic acid, homocystein and methionine. Whole-exome sequencing identified a de novo, truncating mutation in CDKL5 (NM_003159.2:c.419dupA, p.Asn140Lysfs*8). Targeted sequencing excluded concomitant mutations in methylmalonic academia-associated genes. No methylmalonic acidemia has been reported in children with CDKL5 disorder. Extensive analyses on organic acid metabolism for males with CDKL5 mutations will gain more insight into their biochemical profiles in infancy.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CDKL5; De novo mutation; Early-onset epileptic encephalopathy; Methylmalonic acidemia; Whole-exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29510241     DOI: 10.1016/j.ejmg.2018.03.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

Review 1.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

2.  Caregiver's perception of epilepsy treatment, quality of life and comorbidities in an international cohort of CDKL5 patients.

Authors:  S Amin; A Majumdar; A A Mallick; J Patel; R Scatchard; C A Partridge; A Lux
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

3.  X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.

Authors:  Barbara Terzic; Yue Cui; Andrew C Edmondson; Sheng Tang; Nicolas Sarmiento; Daria Zaitseva; Eric D Marsh; Douglas A Coulter; Zhaolan Zhou
Journal:  Neurobiol Dis       Date:  2020-11-13       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.